Search Results - "DE LAFONTAN, B"

Male breast cancer. Evolution of treatment and prognostic factors. Analysis of 489 cases by Cutuli, B, Le-Nir, C. Cohen-Solal, Serin, D, Kirova, Y, Gaci, Z, Lemanski, C, De Lafontan, B, Zoubir, M, Maingon, P, Mignotte, H, Lara, C. Tunon de, Edeline, J, Penault-Llorca, F, Romestaing, P, Delva, C, Comet, B, Belkacemi, Y

“…Abstract Background Infiltrating MBC represents less than 1% of all male cancers. Our study details clinico-pathological features, treatments and prognostic…”
Get full text

Male breast cancer: Results of the treatments and prognostic factors in 397 cases by Cutuli, B., Lacroze, M., Dilhuydy, J.M., Veiten, M., De Lafontan, B., Marchal, C., Resbeut, M., Graic, Y., Campana, F., Moncho-Bernier, V., De Gislain, C., Tortochaux, J., Cuillere, J.C., Reme-Saumon, M., N'Guyen, T.D., Lesaunier, F., Le Simple, T., Gamelin, E., Hery, M., Berlie, J.

“…From 1960 to 1986, 397 cases of non-metastatic male breast cancer (MBC) treated in 14 French regional cancer centres were reviewed. The median age was 64 years…”
Get full text

PO-0685: Locally advanced breast cancer patients with >7 pN+ axillary lymph nodes treated without axillary irradiation by Varela Cagetti, L, Ducassou, A, De Lafontan, B, Massabeau, C

Get full text

Concurrent trastuzumab with adjuvant radiotherapy in HER2-positive breast cancer patients: acute toxicity analyses from the French multicentric study by Belkacémi, Y., Gligorov, J., Ozsahin, M., Marsiglia, H., De Lafontan, B., Laharie-Mineur, H., Aimard, L., Antoine, E.-C., Cutuli, B., Namer, M., Azria, D.

“…Trastuzumab (T) combined with chemotherapy has been recently shown to improve outcome in HER2-positive breast cancer (BC). The aim of this study was to…”
Get full text

Efficacy of a global supportive skin care programme with hydrotherapy after non‐metastatic breast cancer treatment: A randomised, controlled study by Dalenc, F., Ribet, V., Rossi, A.B., Guyonnaud, J., Bernard‐Marty, C., Lafontan, B., Salas, S., Ranc Royo, A.‐L., Sarda, C., Levasseur, N., Massabeau, C., Levecq, J.‐M., Dulguerova, P., Guerrero, D., Sibaud, V.

“…This study investigated the efficacy of post‐treatment hydrotherapy as supportive care for management of persistent/long‐lasting dermatologic adverse events…”
Get full text

Acute toxicity of breast cancer irradiation with modulated intensity by tomotherapy by Aoulad, N, Massabeau, C, de Lafontan, B, Vieillevigne, L, Hangard, G, Ciprian, C, Chaltiel, L, Moyal, É, Izar, F

“…Helical radiation intensity modulated by tomotherapy improves dose distribution to complex and large volumes. The aim of the study was to assess acute toxicity…”
Get full text

Breast-conserving surgery with or without radiotherapy vs mastectomy for ductal carcinoma in situ: French Survey experience by Cutuli, B, Lemanski, C, Fourquet, A, de Lafontan, B, Giard, S, Meunier, A, Pioud-Martigny, R, Campana, F, Marsiglia, H, Lancrenon, S, Mery, E, Penault-Llorca, F, Fondrinier, E, Tunon de Lara, C

“…From March 2003 to April 2004, 77 physicians throughout France prospectively recruited 1289 ductal carcinoma in situ (DCIS) patients and collected data on…”
Get full text

Uncommon dermatologic disorders triggered by radiation therapy of breast cancer: A case-series by Dalmasso, C, Tournier, É, de Lafontan, B, Modesto, A, Dalenc, F, Chantalat, É, Gladieff, L, Jouve, E, Livideanu, C, Izar, F, Sibaud, V

“…Radiotherapy's main skin toxicities are now well-separated, acute (acute radiation dermatitis) or chronic complications (chronic radiation dermatitis, induced…”
Get full text

Ductal carcinoma in situ of the breast in younger women: A subgroup of patients at high risk by Tunon-de-Lara, C, Lemanski, C, Cohen-Solal-Le-Nir, C, de Lafontan, B, Charra-Brunaud, C, Gonzague-Casabianca, L, Mignotte, H, Fondrinier, E, Giard, S, Quetin, P, Auvray, H, Cutuli, B

“…Abstract Background After breast conservative treatment (BCT), young age is a predictive factor for recurrence in patients with Ductal Carcinoma In Situ (DCIS)…”
Get full text

Breast ductal carcinoma in situ with microinvasion: pathological review and clinical implications by Modesto, A, Gandy, C, Mery, E, Filleron, T, Massabeau, C, Izar, F, Charitansky, H, Roché, H, de Lafontan, B

“…Recent improvements in the detection of breast cancer at an early stage have resulted in a rising incidence of breast ductal carcinoma in situ with…”
Get full text

Local recurrence after ductal carcinoma in situ breast conserving treatment. Analysis of 195 cases by Cutuli, B., Lemanski, C., Le Blanc-Onfroy, M., de Lafontan, B., Cohen-Solal-Le-Nir, C., Fondrinier, É., Mignotte, H., Giard, S., Charra-Brunaud, C., Auvray, H., Gonzague-Casabianca, L., Quétin, P., Fay, R.

“…Ductal carcinoma in situ overall prognosis is excellent, but after breast conserving surgery, with or without radiotherapy, local recurrences can lead to…”
Get full text

5168 POSTER Male Breast Cancer (MBC): Optimal Treatment and Diagnosis Factors – Analysis of 636 Cases by Cutuli, B, Bordes, V, Desandes, E, Le Nir, C. Cohen-Solal, Serin, D, Kirova, Y, Comet, B, De Lafontan, B, Baron, M, Zoubir, M

Get full text

Rapidarc vs. tomotherapy for the treatment of chestwall and lymph nodes: A comparative study by Brun, T, Simon, L, de Lafontan, B, Izar, F, Massabeau, C, Lacaze, T, Hangard, G, Vieillevigne, L, Ferrand, R

“…Introduction Treatment of chestwall with lymph nodes (internal mammary and clavicular nodes) is achieved in most of the centers with conventional radiotherapy…”
Get full text

Ductal carcinoma in situ of the breast results of conservative and radical treatments in 716 patients by Cutuli, B., Cohen-Solal-Le Nir, C., De Lafontan, B., Mignotte, H., Fichet, V., Fay, R., Servent, V., Giard, S., Charra-Brunaud, C., Auvray, H., Penault-Llorca, F., Charpentier, J.-C.

“…Until now, less than 5% of the patients with breast ductal carcinoma in situ (DCIS) have been enrolled in clinical trials. Consequently, we have analysed the…”
Get full text

Ductal carcinoma in situ of the breast (DCIS). Histopathological features and treatment modalities: analysis of 1,289 cases by Cutuli, B, Lemanski, C, Fourquet, A, de Lafontan, B, Giard, S, Lancrenon, S, Meunier, A, Pioud-Martigny, R, Campana, F, Marsiglia, H, Mery, E, Penault-Llorca, F, Fondrinier, E, de Lara, C Tunon

“…From March 2003 to April 2004, were prospectively collected in France 1,289 ductal carcinoma in situ (DCIS) with data on diagnosis, patient and tumour…”
Get more information

Summary version of the standards, options and recommendations for nonmetastatic breast cancer (updated January 2001) by Mauriac, L, Luporsi, E, Cutuli, B, Fourquet, A, Garbay, J R, Giard, S, Spyratos, F, Sigal-Zafrani, B, Dilhuydy, J M, Acharian, V, Balu-Maestro, C, Blanc-Vincent, M P, Cohen-Solal, C, De Lafontan, B, Dilhuydy, M H, Duquesne, B, Gilles, R, Lesur, A, Shen, N, Cany, L, Dagousset, I, Gaspard, M H, Hoarau, H, Hubert, A, Monira, M H, Perrié, N, Romieu, G

Get full text

Ductal carcinoma in situ of the male breast. Analysis of 31 cases by Cutuli, B., Dilhuydy, J.M., De Lafontan, B., Berlie, J., Lacroze, M., Lesaunier, F., Graic, Y., Tortochaux, J., Resbeut, M., Lesimple, T., Gamelin, E., Campana, F., Reme-Saumon, M., Moncho-Bernier, V., Cuilliere, J.C., Marchal, C., De Gislain, G., N'Guyen, T.D., Teissier, E., Velten, M.

“…From 1970 to 1992, 31 pure ductal carcinoma in situ (DCIS) of the male breast treated in 19 French Regional Cancer Centres were reviewed. They represent 5% of…”
Get full text

Delayed adjuvant tamoxifen: Ten-year results of a collaborative randomized controlled trial in early breast cancer (TAM-02 trial) by Delozier, T., Switsers, O., Génot, J. Y., Ollivier, J. M., Héry, M., Namer, M., Fresney, M., Kerbrat, P., Veyret, C., de Lafontan, B., Janvier, M., Macé-Lesech, J.

“…Aim: Immediate adjuvant tamoxifen reduces disease recurrence and improves survival in patients with early breast cancer. However, is it too late to administer…”
Get full text

Male breast cancer (MBC). Analysis of treatment strategies in 489 cases by Cutuli, B, Cohen-Solal-Le Nir, C, Serin, D, Kirova, Y, Gaci, Z, Lemanski, C, De Lafontan, B, Zoubir, M, Maingon, P, Belkacemi, Y

Get full text

Isolated clustered microcalcifications: diagnostic value of mammography--series of 400 cases with surgical verification by de Lafontan, B, Daures, J P, Salicru, B, Eynius, F, Mihura, J, Rouanet, P, Lamarque, J L, Naja, A, Pujol, H

“…To determine the diagnostic value of mammographic criteria in cases of isolated clustered microcalcifications. Four hundred mammographic studies of isolated…”
Get more information